Literature DB >> 10491409

Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia.

K Kurahashi1, O Kajikawa, T Sawa, M Ohara, M A Gropper, D W Frank, T R Martin, J P Wiener-Kronish.   

Abstract

The pathogenesis of septic shock occurring after Pseudomonas aeruginosa pneumonia was studied in a rabbit model. The airspace instillation of the cytotoxic P. aeruginosa strain PA103 into the rabbit caused a consistent alveolar epithelial injury, progressive bacteremia, and septic shock. The lung instillation of a noncytotoxic, isogenic mutant strain (PA103DeltaUT), which is defective for production of type III secreted toxins, did not cause either systemic inflammatory response or septic shock, despite a potent inflammatory response in the lung. The intravenous injection of PA103 did not cause shock or an increase in TNF-alpha, despite the fact that the animals were bacteremic. The systemic administration of either anti-TNF-alpha serum or recombinant human IL-10 improved both septic shock and bacteremia in the animals that were instilled with PA103. Radiolabeled TNF-alpha instilled in the lung significantly leaked into the circulation only in the presence of alveolar epithelial injury. We conclude that injury to the alveolar epithelium allows the release of proinflammatory mediators into the circulation that are primarily responsible for septic shock. Our results demonstrate the importance of compartmentalization of inflammatory mediators in the lung, and the crucial role of bacterial cytotoxins in causing alveolar epithelial damage in the pathogenesis of acute septic shock in P. aeruginosa pneumonia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491409      PMCID: PMC408437          DOI: 10.1172/JCI7124

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

Review 1.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 2.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

Authors:  J E Parrillo; M M Parker; C Natanson; A F Suffredini; R L Danner; R E Cunnion; F P Ognibene
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

3.  Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.

Authors:  R R Reddel; Y Ke; B I Gerwin; M G McMenamin; J F Lechner; R T Su; D E Brash; J B Park; J S Rhim; C C Harris
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

4.  Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury.

Authors:  T Sawa; T L Yahr; M Ohara; K Kurahashi; M A Gropper; J P Wiener-Kronish; D W Frank
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

5.  Clinical predictors of the adult respiratory distress syndrome.

Authors:  P E Pepe; R T Potkin; D H Reus; L D Hudson; C J Carrico
Journal:  Am J Surg       Date:  1982-07       Impact factor: 2.565

6.  Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients.

Authors:  A Torres; R Aznar; J M Gatell; P Jiménez; J González; A Ferrer; R Celis; R Rodriguez-Roisin
Journal:  Am Rev Respir Dis       Date:  1990-09

Review 7.  Quantitative aspects of septicemia.

Authors:  P Yagupsky; F S Nolte
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

8.  Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability.

Authors:  T R Martin; B P Pistorese; E Y Chi; R B Goodman; M A Matthay
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

9.  Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin.

Authors:  J P Wiener-Kronish; K H Albertine; M A Matthay
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response.

Authors:  S Nelson; G J Bagby; B G Bainton; L A Wilson; J J Thompson; W R Summer
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

View more
  107 in total

1.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system.

Authors:  Leonard R Allmond; Timur J Karaca; Vinh N Nguyen; Thong Nguyen; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  Ventilator-induced lung injury, cytokines, PEEP, and mortality: implications for practice and for clinical trials.

Authors:  Arthur S Slutsky; Yumiko Imai
Journal:  Intensive Care Med       Date:  2003-08       Impact factor: 17.440

Review 4.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

5.  Orientation of Pseudomonas aeruginosa ExsA monomers bound to promoter DNA and base-specific contacts with the P(exoT) promoter.

Authors:  Jessica M King; Evan D Brutinel; Anne E Marsden; Florian D Schubot; Timothy L Yahr
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

6.  Therapeutic strategy for acute respiratory distress syndrome: recent understanding of the pathophysiology of the disease.

Authors:  Kiyoyasu Kurahashi
Journal:  J Anesth       Date:  2010-12-28       Impact factor: 2.078

7.  Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands.

Authors:  Chanez Chemani; Anne Imberty; Sophie de Bentzmann; Maud Pierre; Michaela Wimmerová; Benoît P Guery; Karine Faure
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

9.  Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.

Authors:  Teiji Sawa; Emi Ito; Vinh Huu Nguyen; Matthew Haight
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.

Authors:  Maureen H Diaz; Ciara M Shaver; John D King; Srinidhi Musunuri; Jeffrey A Kazzaz; Alan R Hauser
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.